Comprehensive Immune Cell Therapy Solutions
Setting the Standard in Immune Cell Therapy, Together
Immune cell therapies are a major advancement in the fight against blood cancers. While most of today’s commercialized therapies use harvested patient cells, increasing demand calls for allogeneic solutions — and developers need robust processes that can scale up, maintain potency, and reduce cost per dose.
Bring your immune cell therapy to market faster and more affordably with end-to-end solutions that deliver reproducible performance and scalability with a simplified path to regulatory approvals.
Spotlight on Success: University College London (UCL)
Overcoming CAR-T Manufacturing Challenges, Together.
Bringing CAR-T therapies to more patients depends on overcoming one of the field’s biggest challenges: manufacturing. In this collaborative story with Dr. Qasim Rafiq’s lab at University College London (UCL), we set out to explore a smarter, more scalable way to grow and harvest CAR-T cells. Through shared expertise and innovative tools, the team demonstrated how process optimization and automation can make the promise of CAR-T manufacturing more achievable, efficient, consistent, and ready to scale.
Immune Cell Therapy Workflow
Solutions for Process Development and Manufacturing
Explore immune cell therapy solutions to simplify progress in every step of your workflow.
Solutions for Immune Cell Therapy
Connected Services
Our process development service simplifies your path to the clinic for cell and gene therapies. Expert support and proven Sartorius technologies help scale processes, reduce variability, and accelerate time-to-market.
Comprehensive analysis of fresh and spent media to confidently monitor the impact of media components and process changes, enabling smarter optimization and more consistent process performance.
Our biologics testing services support product safety, quality, and regulatory compliance from development through commercial manufacturing. cGMP‑compliant testing and expert assays from Sartorius help de‑risk product release, streamline timelines, and accelerate your path to market.
Connected Software & Analytics
DOE software Simplified for Life Science. Ready-to-go connectors for Sartorius equipment & Biobrain Supervise to ease implementation. Backed up with a data science team to get the most out of your data.
Multivariate data analysis software that simplifies your data exploration for Process Experts. Ready-to-go connectors for Sartorius equipment and Biobrain Supervise. Backed up with a data science team to get the most out of your data.
A data acquisition, process control & monitoring system that connects Sartorius and 3rd party unit operations. A scalable system can support 1 to 32 process units to enable PD or GMP production with integration to uMetric for DOE or advanced process control.
Featured Products & Services
Request Your Sample | Raw Materials and Consumables
To help find the right materials and consumables for your needs, request a sample from our portfolio.
More About Immune Cell Therapy From Sartorius
Related Assets
FAQs for Immune Cell Therapy
Immune cell therapy manufacturing is the process of producing a immune cell therapy medicinal product. Immune cell therapies have applications primarily in oncology and autoimmune diseases.
The most prominent types of immune cell therapies are T cells that are genetically engineered to express chimeric antigen receptors (CARs) or T cell recepters (TCRs), and tumor infiltrating lymphocytes (TILs). The other cell types include natural killer (NK) cells and dendritic cells (DCs).
Sartorius provides GMP and automated tools with comprehensive analytics software. Our automated bioreactors use a design of experiments approach to accelerate optimization. We also provide high-quality raw materials suitable for GMP-grade manufacturing, available in a variety of sizes and packaging. Our goal is to enable immune cell therapy developers to achieve reproducible performance at all scales.